The World Health Organization (WHO) has recommended the new malaria vaccine R21/Matrix-M for the prevention of malaria in children.
The approval of the R21 vaccine is expected to result in sufficient vaccine supply to benefit all children living in areas where malaria is a public health risk.
The R21 vaccine is the second malaria vaccine to be recommended by WHO. In 2021, WHO recommended the RTS,S/AS01 vaccine. Both vaccines are safe and effective in preventing malaria in children.
疟疾每年导致超过 600,000 人死亡。 2021 年，估计有 2.47 亿例疟疾病例，其中 95% 病例发生在世卫组织非洲区域。 5 岁以下儿童是受疟疾影响最脆弱的群体。
Malaria vaccines have taken decades to develop due to the complicated structure of the malaria parasite. Earlier this year, Ghana was the first country to approve the R21 vaccine.
WHO: WHO recommends R21/Matrix-M vaccine for malaria prevention